Atezolizumab as the First Systemic Therapy Approved for Alveolar Soft Part Sarcoma.
Ann Pharmacother
; 58(4): 407-415, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-37466080
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoma, Alveolar Soft Part
/
B7-H1 Antigen
Limits:
Adult
/
Child
/
Humans
Language:
En
Journal:
Ann Pharmacother
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2024
Document type:
Article
Affiliation country:
United States
Country of publication:
United States